UPDATE - Barclays Downgraded Pfizer (PFE) to Equalweight; Inferior Revenue Recovery Post 'Patent Cliff' Through 2020

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. TGT
2. EL
3. WMT
4. SPY
5. ROST
6. BILL
7. ADI
8. MRK
9. MRNA
10. NTES

Go back to UPDATE - Barclays Downgraded Pfizer (PFE) to Equalweight; Inferior Revenue Recovery Post 'Patent Cliff' Through 2020
Bristol-Myers Squibb (NYSE: BMY) Delayed: 65.47 --0 (-0%)
Previous Close $65.47    52 Week High $77.12 
Open $65.47    52 Week Low $49.03 
Day High $65.47    P/E 42.51 
Day Low $65.47    EPS $1.54 
Volume 341       

Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1244.40 --0 (-0%)
Previous Close $1244.40    52 Week High $88.16 
Open $1244.40    52 Week Low $67.88 
Day High $1244.40    P/E 288.06 
Day Low $1244.40    EPS $4.32 
Volume 2,116       

Merck & Co. (NYSE: MRK) Delayed: 148.99 --0 (-0%)
Previous Close $148.99    52 Week High $65.46 
Open $148.99    52 Week Low $47.97 
Day High $148.99    P/E 101.35 
Day Low $148.99    EPS $1.47 
Volume 8,570       

Pfizer Inc. (NYSE: PFE) Delayed: 27.79 --0 (-0%)
Previous Close $27.79    52 Week High $37.39 
Open $27.79    52 Week Low $28.25 
Day High $27.79    P/E 16.84 
Day Low $27.79    EPS $1.65 
Volume 34,704